Home / Market News / $ALHC
fiscal.ai Corporate Catalyst Impact 85/100 ● negative

Alignment Healthcare Reports Third Quarter 2026 Financial Results

Oct 29, 2026, 9:35 PM UTC · Primary ticker $ALHC

Alignment Healthcare reported strong Q3 revenue and membership growth but significantly lowered its full-year adjusted gross profit and EBITDA guidance due to higher medical costs. This guidance cut signals potential profitability challenges despite top-line expansion, likely leading to negative market reaction.

Alignment Healthcare announced its Q3 2026 financial results, showing robust revenue growth of 36.7% year-over-year and a 31.2% increase in health plan membership. However, the company simultaneously lowered its full-year 2026 adjusted gross profit and adjusted EBITDA guidance, attributing this to higher medical costs experienced in Q3. This is a significant negative development for investors as it indicates that despite strong top-line growth, profitability is under pressure. The short-term implication is likely a negative market reaction to ALHC stock due to the guidance cut, while the long-term implications depend on the company's ability to manage medical costs and return to its previous profitability trajectory. Traders should note the immediate downside risk due to the revised outlook.

$ALHC negative Lowered full-year guidance despite revenue growth
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.